1. Middle cerebral artery blood flow velocity during a 4 km cycling time trial
- Author
-
Ben Rattray, Disa J. Smee, Nathan G. Versey, Joseph M. Northey, and Brittany A. Smale
- Subjects
Adult ,Male ,Middle Cerebral Artery ,Mean arterial pressure ,medicine.medical_specialty ,Adolescent ,Physiology ,03 medical and health sciences ,Oxygen Consumption ,0302 clinical medicine ,Time trial ,Physiology (medical) ,medicine.artery ,Internal medicine ,Heart rate ,medicine ,Humans ,Orthopedics and Sports Medicine ,Exercise ,business.industry ,Public Health, Environmental and Occupational Health ,030229 sport sciences ,General Medicine ,Blood flow ,Transcranial Doppler ,Cerebral blood flow ,Cerebrovascular Circulation ,Middle cerebral artery ,Physical therapy ,Cardiology ,Cycling ,business ,Blood Flow Velocity ,030217 neurology & neurosurgery - Abstract
This study sought to describe middle cerebral artery blood flow velocity (MCAv) during a 4 km cycling time trial, and relate it to different pacing strategies adopted by participants. After familiarisation and a standardised exercise protocol, 15 male trained cyclists rode a 4 km time trial on a cycling ergometer. MCAv was assessed via transcranial Doppler ultrasound in the right hemisphere at resting baseline, and throughout the time trial. Mean arterial pressure, end-tidal partial pressure of carbon dioxide (PetCO2) and heart rate were assessed alongside MCAv. Plasma lactate was assessed post time trial. Data were compared depending upon whether participants completed the time trial with a positive (first half faster than the last) or negative pacing profile although there was no difference in the time to completion with either pacing strategy (positive 344 ± 23 s, negative 334 ± 14 s; p = 0.394). Lower mean MCAv (positive pacing −7.6 ± 14.2%, negative pacing +21.2 ± 15.0% compared to resting baseline measures; p = 0.004) and lower PetCO2 (significant interaction p
- Published
- 2017
- Full Text
- View/download PDF